Advancing Relapse Prediction in Pediatric AML Through Genomic MRD
Ryan Quigley
Amanda Winters, MD, PhD
Neighborhood Archetypes and Patient Outcomes in Pediatric ALL and AML
Charles Turck, PharmD, BCPS, BCCCP
Lena Winestone, MD, MSHP
Improving BCC Screening in Childhood Cancer Survivors Through Risk Modeling
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
Ryan D. Cassaday, MD
Daniel J. DeAngelo, MD, PhD
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Alexandria May, PharmD, BCPS
Nicholas Whipple, MD, MPH
Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Kathrin M. Bernt, MD
Rushabh Mehta, BS
Fatemeh Alikarami
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Daniel Landi, MD
Real-World Cases in Pediatric Low-Grade Glioma: Exploring Targeted Therapies
Angela Waanders, MD, MPH, MS
Ashley S. Margol, MD, MS
Consensus and Standards to Improve Continuity of Care in Sickle Cell Disease
Targeting RET Alterations: Selpercatinib's Role in Pediatric Thyroid Cancer
Pediatric Oncofertility: Key Considerations & Procedures
Jacob Sands, MD
Yasmin Jayasinghe, FRANZCOG, PhD
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Shira Johnson, MD
Robert Vonderheide, MD
The Most Common Pediatric Cancer: Acute Lymphoblastic Leukemia
Bruce Bloom, DDS, JD
Stephen Hunger, MD
Genetic Research into Hypodiploid ALL
Charles Mullighan, MBBS, MSc, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.